Blog

• 
• 
• 
• 

Two Vanderbilt Eye Institute (VEI) researchers were recently awarded National Eye Institute (NEI) Audacious Goals Initiative (AGI) for Regenerative Medicine grants for $6.8 million over five years to develop new treatments for optic neuropathies and glaucoma, the leading cause of irreversible blindness.

Single-cell RNA sequencing is a powerful tool for studying cellular diversity, for example in cancer where varied tumor cell types determine diagnosis, prognosis and response to therapy.

Pulmonary-renal syndrome (PRS) refers to a group of rare but potentially fatal conditions that nearly always are caused by a misguided attack by the body’s immune system on the lungs and kidneys. Coughing up blood and blood in the urine are telltale signs.

The Office of the Provost invites faculty to submit proposals for the next round of Discovery Grants and Research Scholar Grants.

Both awards are open to all full-time VU-employed (provost-reporting) faculty. Proposals that advance research in areas related to race, diversity and inclusivity are encouraged.

Five Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.

Small cell lung cancer (SCLC) represents up to 25 percent of lung cancer cell deaths and is associated with early metastasis and poor patient survival.

Researchers at Vanderbilt University Medical Center have identified a biomarker for insulin-producing beta cells.

Cancers of the tonsils and the base of the tongue related to the human papillomavirus (HPV) are frequently small, often with no early-stage symptoms, so many patients go undiagnosed until tumors have spread to lymph nodes in the neck.